aparoscopic ICG fluorescence imaging surgery.
Phase 2
Recruiting
- Conditions
- patients who underwent surgery
- Registration Number
- JPRN-jRCTs041180006
- Lead Sponsor
- Takamura Hiroyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
1) Cases requiring surgery.
2) 20 years old and more.
3) Suitable for surgery under general anesthesia.
4) Having a potential demand for a detection of vessels arteries, bile ducts, or lymphatics under the fatty layer.
Exclusion Criteria
1) Having allergy for ICG.
2) Having allergy for iodic contrast medium.
3) Having allergy for various drugs.
4) Having psychological or neurological disease.
5) Difficult to draw an informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The detection rate of the target. Or, the occurrence rate of the anastomotic leakage or necrosis of the graft.
- Secondary Outcome Measures
Name Time Method The occurrence of the adverse effect of ICG, such as the allergic reaction for ICG, incidences during the injection of ICG, or postoperative complications related to ICG.